Logo

OpiCalc

FavoritesSpecialtiesDrugsGuidelinesMost Used

All Specialties

OpiCalc Logo
FavoritesSpecialtiesDrugsGuidelinesMost Used
FavesSpecsDrugsGuidesTop
BPH Impact IndexBosniak ClassificationCAPRA ScoreD'Amico Risk ClassificationEAU NMIBC Risk Groups (2021)EORTC Risk Tables for NMIBCFournier's Gangrene Severity IndexGUPI (Genitourinary Pain Index)Guy's Stone ScoreICIQ-UI SFIGCCCG ClassificationIIEF-5 / SHIMIIQ-7IMDC (Heng) Risk CriteriaIPSS ScoreNIH-CPSIOAB-V8PADUA Prediction ScorePI-RADS v2.1PSA DensityR.E.N.A.L. Nephrometry ScoreResidual Volume (PVR)S.T.O.N.E. NephrolithometrySFU Hydronephrosis GradingUDI-6VUR Grading
OpiCalc Logo

OpiCalc

Easy, fast, and private medical tools for clinicians. Always free.

No Login Required
Ready for the Bedside

Resources

About UsEditorial PolicyMedical DisclaimerPrivacy PolicyTerms of UseCookie Policy

Support

Contact Us

Clinical Notice:OpiCalc is not a substitute for professional clinical judgment. Always verify dosages and guidelines.

OpiCalc © 2018-2026

•

All Rights Reserved

Recent Journal Updates

British J Clinical PharmacologyJun 18, 2026
Applying machine learning to pharmacovigilance data: A proof‐of‐concept study

Clinical Context

We think this has broad domain relevance to OABV 8.

OAB-V8

Overactive Bladder Screening — Past 4 Weeks

OAB-V8 Questionnaire

How bothered have you been by each of the following symptoms in the past 4 weeks?

1. Frequent urination during the daytime hours

2. An uncomfortable urge to urinate

3. A sudden urge to urinate with little or no warning

4. Accidental loss of urine associated with a sudden urge to urinate

5. Nighttime urination

6. Waking up at night because you had to urinate

7. An uncontrollable urge to urinate

8. Urine loss associated with a strong desire to urinate

Awaiting Responses

Answer all 8 questions to calculate the OAB-V8 score.

Guidelines & Evidence

Verified

Last Review: 2026

When to Use

When to Use the OAB-V8

Screening for overactive bladder (OAB) in patients presenting with urinary urgency, frequency, nocturia, or urge incontinence
Rapid assessment in primary care, gynecology, or urology clinics to identify patients who warrant further evaluation
Differentiating storage symptoms from other lower urinary tract symptoms (LUTS)
Baseline measurement before initiating treatment for OAB (behavioral therapy, anticholinergics, beta-3 agonists, neuromodulation)
Monitoring treatment response and patient-reported bother over time
Population screening or research studies involving bladder symptoms
Helping decide when to refer to specialist (urogynecology or urology)

Clinical Context

Overactive bladder (OAB) is a highly prevalent syndrome defined by urgency, with or without urge incontinence, usually accompanied by frequency and nocturia. It affects approximately 12–17% of adults and has a major negative impact on quality of life, sleep, productivity, and mental health. The OAB-V8 is a short, validated, patient-reported screening tool designed specifically for use in busy clinical settings to identify individuals likely to have OAB who would benefit from targeted evaluation and management.

Symptoms Targeted by OAB-V8

Urinary urgency (sudden compelling desire to pass urine)
Frequency (urinating too often during the day)
Nocturia (waking at night to urinate)
Urge urinary incontinence (leakage associated with urgency)
Overall bother from bladder symptoms

Last Comprehensive Review: 2026